aTyr Pharma Obtains $23,000,000 Series C Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37565c00-e646-4307-a248-1c7a2998870c&Preview=1 -
Date
10/26/2010 -
Company Name
aTyr Pharma -
Mailing Address
3565 General Atomics Court San Diego, CA 92121 -
Company Description
We have developed proprietary methods for discovering Physiocrines, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts. -
Website
http://www.atyrpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$23,000,000 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds will be used to accelerate the development of aTyr’s preclinical pipeline and advance physiocrine drug candidates into clinical trials. -
M&A Terms
-
Venture Investor
Domain Associates -
Venture Investor
Alta Partners -
Venture Investor
Cardinal Partners -
Venture Investor
Polaris Venture Partners
